580 related articles for article (PubMed ID: 1409431)
1. Epidemiology of malignant melanoma in central Europe: risk factors and prognostic predictors. Results of the Central Malignant Melanoma Registry of the German Dermatological Society.
Garbe C; Orfanos CE
Pigment Cell Res; 1992; Suppl 2():285-94. PubMed ID: 1409431
[TBL] [Abstract][Full Text] [Related]
2. Melanocytic nevi and risk of cutaneous malignant melanoma in southern Spain.
Ródenas JM; Delgado-Rodríguez M; Farinas-Alvarez C; Herranz MT; Serrano S
Am J Epidemiol; 1997 Jun; 145(11):1020-9. PubMed ID: 9169911
[TBL] [Abstract][Full Text] [Related]
3. Comparative analysis of incidence and clinical features of cutaneous malignant melanoma in Crete (Greece) and southern Germany (central Baden-Württemberg).
Lasithiotakis K; Leiter U; Krüger-Krasagakis S; Tosca A; Garbe C
Br J Dermatol; 2006 Jun; 154(6):1123-7. PubMed ID: 16704644
[TBL] [Abstract][Full Text] [Related]
4. Sun exposure, phenotypic characteristics, and cutaneous malignant melanoma. An analysis according to different clinico-pathological variants and anatomic locations (Italy).
Naldi L; Altieri A; Imberti GL; Gallus S; Bosetti C; La Vecchia C;
Cancer Causes Control; 2005 Oct; 16(8):893-9. PubMed ID: 16132799
[TBL] [Abstract][Full Text] [Related]
5. [The sun and malignant melanoma].
Garbe C
Hautarzt; 1992 May; 43(5):251-7. PubMed ID: 1612913
[TBL] [Abstract][Full Text] [Related]
6. Trends in incidence of various morphologies of malignant melanoma in Vaud and Neuchatel, Switzerland.
Levi F; Te VC; Randimbison L; La Vecchia C
Melanoma Res; 2005 Feb; 15(1):73-5. PubMed ID: 15714124
[TBL] [Abstract][Full Text] [Related]
7. [The Malignant Melanoma Central Register of the German Society of Dermatology 1983-1993. Epidemiologic developments and current therapeutic management of malignant melanoma of the skin].
Garbe C; Büttner P; Ellwanger U; Bröcker EB; Jung EG; Orfanos CE; Rassner G; Wolff HH
Hautarzt; 1995 Oct; 46(10):683-92. PubMed ID: 7499127
[TBL] [Abstract][Full Text] [Related]
8. Melanocytic naevi, melanoma and sun exposure.
Augustsson A
Acta Derm Venereol Suppl (Stockh); 1991; 166():1-34. PubMed ID: 1814137
[TBL] [Abstract][Full Text] [Related]
9. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe.
Garbe C; McLeod GR; Buettner PG
Cancer; 2000 Sep; 89(6):1269-78. PubMed ID: 11002222
[TBL] [Abstract][Full Text] [Related]
10. Development of prognostic factors and survival in cutaneous melanoma over 25 years: An analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Buettner PG; Leiter U; Eigentler TK; Garbe C
Cancer; 2005 Feb; 103(3):616-24. PubMed ID: 15630700
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiology of malignant melanoma in West Germany in an international comparison].
Garbe C; Orfanos CE
Onkologie; 1989 Dec; 12(6):253-62. PubMed ID: 2696908
[TBL] [Abstract][Full Text] [Related]
12. Epidemiologic evidence for the role of melanocytic nevi as risk markers and direct precursors of cutaneous malignant melanoma. Results of a case control study in melanoma patients and nonmelanoma control subjects.
Krüger S; Garbe C; Büttner P; Stadler R; Guggenmoos-Holzmann I; Orfanos CE
J Am Acad Dermatol; 1992 Jun; 26(6):920-6. PubMed ID: 1607409
[TBL] [Abstract][Full Text] [Related]
13. Is head and neck melanoma a distinct entity? A clinical registry-based comparative study in 5702 patients with melanoma.
Hoersch B; Leiter U; Garbe C
Br J Dermatol; 2006 Oct; 155(4):771-7. PubMed ID: 16965427
[TBL] [Abstract][Full Text] [Related]
14. [Dubreuilh melanoma: and epidemiologic and prognostic study].
Tournillac I; Picot MC; Dereure O; Guilhou JJ; Guillot B
Ann Dermatol Venereol; 1999 Oct; 126(10):676-80. PubMed ID: 10604003
[TBL] [Abstract][Full Text] [Related]
15. Prognostic factors for cutaneous malignant melanoma in Vaud, Switzerland.
Levi F; Randimbison L; La Vecchia C; Te VC; Franceschi S
Int J Cancer; 1998 Oct; 78(3):315-9. PubMed ID: 9766565
[TBL] [Abstract][Full Text] [Related]
16. Cutaneous malignant melanoma incidence and mortality trends in Canada: A comprehensive population-based study.
Ghazawi FM; Cyr J; Darwich R; Le M; Rahme E; Moreau L; Netchiporouk E; Zubarev A; Roshdy O; Glassman SJ; Sasseville D; Litvinov IV
J Am Acad Dermatol; 2019 Feb; 80(2):448-459. PubMed ID: 30092328
[TBL] [Abstract][Full Text] [Related]
17. [Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study].
Weiss J; Garbe C; Bertz J; Biltz H; Burg G; Hennes B; Jung EG; Kreysel HW; Orfanos CE; Petzold D
Hautarzt; 1990 Jun; 41(6):309-13. PubMed ID: 2380066
[TBL] [Abstract][Full Text] [Related]
18. Incidence and mortality of malignant melanoma in Berlin (West) from 1980 to 1986.
Garbe C; Thiess S; Nürnberger F; Ehlers G; Albrecht G; Lindlar F; Bertz J
Acta Derm Venereol; 1991; 71(6):506-11. PubMed ID: 1685833
[TBL] [Abstract][Full Text] [Related]
19. Time trends in features of cutaneous melanoma at diagnosis: central-south Italy, 1962-1991.
Cavalieri R; Macchini V; Mostaccioli S; Sonego G; Ferranti G; Corona R; Fucci M; Marzolini F; Rosmini F; Pasquini P
Ann Ist Super Sanita; 1993; 29(3):469-72. PubMed ID: 8172468
[TBL] [Abstract][Full Text] [Related]
20. Change of epidemiological characteristics of malignant melanoma during the years 1962-1972 and 1983-1986 in the Federal Republic of Germany.
Garbe C; Wiebelt H; Orfanos CE
Dermatologica; 1989; 178(3):131-5. PubMed ID: 2656326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]